Growth Metrics

Travere Therapeutics (TVTX) Gross Profit Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.94%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.76%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 16.94%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,488.21%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 47.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 47.72%
Dec 31, 2025 -590.48%
Sep 30, 2025 -37.30%
Jun 30, 2025 116.94%
Mar 31, 2025 73.83%
Dec 31, 2024 78.38%
Sep 30, 2024 71.12%
Jun 30, 2024 69.32%
Mar 31, 2024 49.09%
Dec 31, 2023 42.23%
Sep 30, 2023 32.81%
Jun 30, 2023 15.65%
Mar 31, 2023 25.71%
Dec 31, 2022 118.11%
Sep 30, 2022 -49.52%
Jun 30, 2022 -49.81%
Mar 31, 2022 -53.51%
Dec 31, 2021 -421.34%
Sep 30, 2021 6.92%
Jun 30, 2021 12.85%
Mar 31, 2021 -1.37%
Dec 31, 2020 8.78%
Sep 30, 2020 16.54%
Jun 30, 2020 7.34%
Mar 31, 2020 20.35%
Dec 31, 2019 6.63%
Sep 30, 2019 8.31%
Jun 30, 2019 8.89%
Mar 31, 2019 4.71%
Dec 31, 2018 2.84%
Sep 30, 2018 0.40%
Jun 30, 2018 5.67%
Mar 31, 2018 11.87%
Dec 31, 2017 13.51%
Sep 30, 2017 21.76%
Jun 30, 2017 17.69%
Mar 31, 2017 16.49%
Dec 31, 2016 21.69%
Sep 30, 2016 17.75%
Jun 30, 2016 37.81%
Mar 31, 2016 65.23%
Dec 31, 2015 115.95%
Sep 30, 2015 237.33%
Jun 30, 2015 310.57%
Mar 31, 2015 62,992.25%